PMEG
PMEG is a nuclear DNA polymerases α, δ, and ε inhibitor that causes DNA chain termination, inhibits DNA synthesis, induces cytotoxicity in dividing cells. PMEG is an acyclic nucleotide phosphonate that forms an active phosphorylated metabolite, PMEG diphosphate, within cells. PMEG has activity against leukemia and melanoma in rodent models. PMEG has poor cell permeability; its prodrug is Rabacfosadine (GS-9219) (HY-13640). PMEG shows antiviral activity against against various DNA virus infections including murine cytomegalovirus (MCMV) and human cytomegalovirus (HCMV). PMEG can be used for the research of non-hodgkin's lymphoma[1][2].
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 114088-58-3
- Formule: C8H12N5O5P
- Masse moléculaire:289.19
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform DNA/RNA Synthesis
More
Activité biologique
|
DNA Polymerase |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Ca-Ski | EC50 |
5530 nM
Compound: PMEG
|
Antiproliferative activity against HPV-transformed human CaSki cells after 7 days by SRB assay
Antiproliferative activity against HPV-transformed human CaSki cells after 7 days by SRB assay
|
[PMID: 19398642] |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 114088-58-3
-
Masse moléculaire 289.19
-
Formule C8H12N5O5P
-
SMILES
O=C1N=C(NC2=C1N=CN2CCOCP(O)(O)=O)N
-
Synonyms
9-(2-Phosphonylmethoxy)ethylguanine
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Kim HT, et al. Antiviral activity of 9-[[(ethoxyhydroxyphosphinyl)-methoxy]methoxy] guanine against cytomegalovirus and herpes simplex virus. Antiviral Res. 1995 Nov;28(3):243-51. [Content Brief]
[2]. Vail DM, et al. Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma. Clin Cancer Res. 2009;15(10):3503-3510. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- PMEG
- 114088-58-3
- 9-(2-Phosphonylmethoxy)ethylguanine
- DNA/RNA Synthesis
- CMV
- lymphoid cells
- DNA synthesis
- dividing cells
- leukemia
- rodent models
- client-owned pet dogs
- cytotoxicity
- anticancer agent
- ε
- high-proliferation lymphoid malignancies
- non-hodgkin's lymphoma
- spontaneous non-Hodgkin's lymphoma
- nuclear DNA polymerases α
- δ
- DNA chain termination
- melanoma
- Inhibitor
- inhibitor
- inhibit